PacBio Announces PacBio Capital
September 12, 2023
New Program Expands Access to PacBio's Highly Accurate Sequencing Systems by Providing Flexible Financing MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced PacBio Capital, a program that offers customers the ability to lease PacBio sequencing systems – Revio, Onso and Sequel IIe – easily and cost-effectively. [...]
September 12, 2023
News Summary: Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses. New pre-developed LC-MS analytical workflows make it even easier for bioprocess engineers with limited LC-MS experience to accelerate upstream process development by up to six [...]
INTEGRA Biosciences’ pipettes help clinics to tackle the opioid epidemic
September 12, 2023
Axis Healthcare, a family-run care facility in Oklahoma, has introduced VOYAGER adjustable tip spacing pipettes from INTEGRA Biosciences into its PCR laboratory workflows. These multichannel pipettes offer the laboratory a straightforward and easy-to-use liquid handling solution to provide accurate and high throughput testing as part of a holistic strategy to support patients in overcoming opioid [...]
Repligen Appoints Jason K. Garland as Chief Financial Officer
September 12, 2023
WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed Jason K. Garland as Chief Financial Officer (“CFO”), effective September 25, 2023. Mr. Garland is joining Repligen from his most recent role with medical device outsource (MDO) manufacturer Integer Holdings Corporation (“Integer”), where he [...]
Change of Chief Financial Officer at Carl Zeiss AG
September 12, 2023
Oberkochen, Germany -- After more than 20 years at ZEISS, the Chief Financial Officer (CFO) of Carl Zeiss AG, Dr. Christian Müller, has decided not to extend his contract for another term. He has informed the Supervisory Board and will leave the company at his own request on 30 September 2023. “ZEISS continues its dynamic, [...]
TRESCAL ACQUIRES QUALITY SERVICE TO PENETRATE LIFE SCIENCE MARKET IN ITALY
September 11, 2023
Paris, France – Trescal, the global leader in calibration services, announced that it has acquired Quality Service to gain entry to the Italian life science market and reinforce its geographic coverage. Quality Service represents 4.5M€ in sales and employs 30 people. Founded in 1996, Quality Service provides accredited calibration, qualification and validation services to major players [...]
September 11, 2023
InSphero and Darwin Microfluidics signed distribution agreement to facilitate purchasing InSphero’s 3D in vitro products within the European Union Zurich, Switzerland – InSphero today announced that the company is making their 3D in vitro products available to researchers in the European Union market more easily by signing a distribution agreement with Darwin Microfluidics, an innovative startup dedicated to bringing advanced microfluidic solutions [...]
September 11, 2023
A major bottleneck in drug discovery, particularly when targeting transmembrane proteins such as G-coupled receptor proteins (GPCRs), is the challenge of replicating in vitro the precise microenvironment conditions found inside a cell. These conditions are essential for maintaining the native conformation and normal activity of these proteins. To address this critical issue, Celtarys and G.CLIPS are thrilled [...]
Introducing Flowraissance™: Stratedigm Technology Defies Obsolescence Trends
September 11, 2023
At Stratedigm, our vision has always been to build lasting flow cytometers and nurture lasting partnerships. Today, we are excited to introduce our newest customer care program. Named Flowraissance™ (FLOW-rah-sahns) in the spirit of the ideals of revival, exploration, and intellectual and scientific progress, the program aims to breathe new life into your trusted S1000 flow cytometer, empowering you [...]
Jennifer Meade Named President
September 11, 2023
FARGO, N.D. – Jennifer Meade has been named President of Aldevron, effective September 11th 2023, as part of a planned leadership transition. She replaces Kevin Ballinger, who has departed Aldevron after leading the organization for three years. Since joining Aldevron in October 2022 as General Manager, Nucleic Acids, Meade has been an active leader of Aldevron strategic initiatives including [...]

